Download PDF
Am J Perinatol
DOI: 10.1055/a-2521-1020
Original Article

The Prevalence of Septo-Optic Dysplasia in Neonates with Absent Cavum Septi Pellucidi Identified during Routine Prenatal Imaging

Michael A. Phillipi
1   School of Medicine, California University of Science and Medicine, Colton, California
,
Sheevaun Khaki
2   Department of Pediatrics, Oregon Health & Science University, Portland, Oregon
,
Amanda J.H. Kim
3   Department of Pediatrics, University of Washington, Seattle, Washington
,
Michael F. Regner
4   Department of Radiology, Neuroradiology Section, Oregon Health & Science University, Portland, Oregon
,
Ladawna Gievers
2   Department of Pediatrics, Oregon Health & Science University, Portland, Oregon
› Author Affiliations Funding None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective This study aimed to determine the prevalence of septo-optic dysplasia (SOD) in patients with prenatally identified absent cavum septi pellucidi (CSP), agenesis of the corpus callosum (ACC), or dysgenesis of the corpus callosum (DCC).

Study Design This retrospective chart review investigated neonates prenatally diagnosed with an absent CSP, ACC, or DCC who were admitted to a single quaternary academic medical center in the Pacific Northwest between 2016 and 2023. This prenatal diagnosis prompted a routine and protocolized postnatal workup for SOD including laboratory evaluation, imaging, and specialty consultation. Sociodemographic and clinical data were collected for eligible neonates and their birthing persons. The prevalence of SOD in patients with midline callososeptal anomalies was calculated.

Results Of the 86 patients prenatally diagnosed with absent CSP, ACC, and/or DCC, 36.0% (n = 31) were diagnosed postnatally with SOD. Of those diagnosed with SOD, 71.0% (n = 22) had isolated optic nerve hypoplasia, 9.7% (n = 3) had pituitary hormone abnormalities, and 19.4% (n = 6) had both. Seven patients required maintenance hydrocortisone, one required thyroid hormone replacement, and one required thyroid and growth hormones. Of the 26 patients with SOD who underwent genetic testing, 9 (34.6%) had one or more genetic differences detected.

Conclusion SOD was diagnosed in 36.0% of cases of prenatally diagnosed midline callososeptal anomalies. For patients with prenatally diagnosed midline callososeptal anomalies, a standardized, postnatal SOD evaluation allows timely diagnosis and prompts early intervention and hormone replacement, thus avoiding the consequences of a delayed diagnosis.

Key Points

  • Thirty-six percent of patients with midline callososeptal anomalies were diagnosed with SOD.

  • Most patients (71.0%) diagnosed with SOD had optic nerve hypoplasia without pituitary abnormalities.

  • Although most patients received genetic testing, no findings were linked to SOD.

Keywords

septo-optic dysplasia - cavum septi pellucidi - corpus callosum - midline brain defects - callososeptal anomalies

Authors' Contributions

All authors were involved in the design, analysis, and interpretation of the data reported in this study.




Publication History

Received: 25 May 2024

Accepted: 20 January 2025

Accepted Manuscript online:
21 January 2025

Article published online:
14 February 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Winter T, Toscano MM. Proper Latin terminology for the cavum septi pellucidi. AJR Am J Roentgenol 2011; 197 (06) W1170
    CrossrefPubMedSearch in Google Scholar
  • 2 Kaude JV. Commonly made error in Latin terminology. AJR Am J Roentgenol 2002; 179 (06) 1645
    CrossrefPubMedSearch in Google Scholar
  • 3 Raybaud C. The corpus callosum, the other great forebrain commissures, and the septum pellucidum: anatomy, development, and malformation. Neuroradiology 2010; 52 (06) 447-477
    CrossrefPubMedSearch in Google Scholar
  • 4 Sarwar M. The septum pellucidum: normal and abnormal. AJNR Am J Neuroradiol 1989; 10 (05) 989-1005
    PubMedSearch in Google Scholar
  • 5 Falco P, Gabrielli S, Visentin A, Perolo A, Pilu G, Bovicelli L. Transabdominal sonography of the cavum septum pellucidum in normal fetuses in the second and third trimesters of pregnancy. Ultrasound Obstet Gynecol 2000; 16 (06) 549-553
    CrossrefPubMedSearch in Google Scholar
  • 6 Ben M'Barek I, Tassin M, Guët A. et al. Antenatal diagnosis of absence of septum pellucidum. Clin Case Rep 2020; 8 (03) 498-503
    CrossrefPubMedSearch in Google Scholar
  • 7 Webb EA, Dattani MT. Septo-optic dysplasia. Eur J Hum Genet 2010; 18 (04) 393-397
    CrossrefPubMedSearch in Google Scholar
  • 8 Signorini SG, Decio A, Fedeli C. et al. Septo-optic dysplasia in childhood: the neurological, cognitive and neuro-ophthalmological perspective. Dev Med Child Neurol 2012; 54 (11) 1018-1024
    CrossrefPubMedSearch in Google Scholar
  • 9 Mann A, Aghababaie A, Kalitsi J, Martins D, Paloyelis Y, Kapoor RR. Neurodevelopmental impairments in children with septo-optic dysplasia spectrum conditions: a systematic review. Mol Autism 2023; 14 (01) 26
    CrossrefPubMedSearch in Google Scholar
  • 10 Al-Salihi MM, Qassim T, Aji N, Al-Jebur MS, Rahman MM, Ayyad A. The clinical aspects of septo-optic dysplasia: a narrative review with illustrative case report. Int J Surg Case Rep 2023; 109: 108575
    CrossrefPubMedSearch in Google Scholar
  • 11 Di Pasquo E, Kuleva M, Arthuis C. et al. Prenatal diagnosis and outcome of fetuses with isolated agenesis of septum pellucidum: cohort study and meta-analysis. Ultrasound Obstet Gynecol 2022; 59 (02) 153-161
    CrossrefPubMedSearch in Google Scholar
  • 12 Shinar S, Blaser S, Chitayat D. et al. Long-term postnatal outcome of fetuses with prenatally suspected septo-optic dysplasia. Ultrasound Obstet Gynecol 2020; 56 (03) 371-377
    CrossrefPubMedSearch in Google Scholar
  • 13 Pickup EES, Schlatterer SD, du Plessis AJ, Mulkey SB. Isolated absent septum pellucidum: a retrospective study of fetal diagnosis and postnatal outcomes. Pediatr Neurol 2022; 136: 8-14
    CrossrefPubMedSearch in Google Scholar
  • 14 Vawter-Lee MM, Wasserman H, Thomas CW. et al. Outcome of isolated absent septum pellucidum diagnosed by fetal magnetic resonance imaging (MRI) scan. J Child Neurol 2018; 33 (11) 693-699
    CrossrefPubMedSearch in Google Scholar
  • 15 Karl K, Esser T, Heling KS, Chaoui R. Cavum septi pellucidi (CSP) ratio: a marker for partial agenesis of the fetal corpus callosum. Ultrasound Obstet Gynecol 2017; 50 (03) 336-341
    CrossrefPubMedSearch in Google Scholar
  • 16 Hebebrand M, Hüffmeier U, Trollmann R. et al. The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy. Orphanet J Rare Dis 2019; 14 (01) 38
    CrossrefPubMedSearch in Google Scholar
  • 17 Patel L, McNally RJ, Harrison E, Lloyd IC, Clayton PE. Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in Northwest England. J Pediatr 2006; 148 (01) 85-88
    CrossrefPubMedSearch in Google Scholar
  • 18 Wisner KL, Jennings KD, Conley B. Clinical dilemmas due to the lack of inpatient mother-baby units. Int J Psychiatry Med 1996; 26 (04) 479-493
    CrossrefPubMedSearch in Google Scholar
  • 19 Pavlyshyn H, Sarapuk I, Saturska U. Maternal stress experience in the neonatal intensive care unit after preterm delivery. Am J Perinatol 2024; 41 (09) 115-1162
    PubMedSearch in Google Scholar
  • 20 McCabe MJ, Alatzoglou KS, Dattani MT. Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract Res Clin Endocrinol Metab 2011; 25 (01) 115-124
    CrossrefPubMedSearch in Google Scholar
  • 21 Reis LM, Seese S, Maheshwari M. et al. University Of Washington Center For Mendelian Genomics. Novel genetic diagnoses in septo-optic dysplasia. Genes (Basel) 2022; 13 (07) 1165
    CrossrefPubMedSearch in Google Scholar
  • 22 Salman MS, Ruth CA, Yogendran MS, Rozovsky K, Lix LM. Risk factors in children with optic nerve hypoplasia and septo-optic dysplasia. Dev Med Child Neurol 2024; 66 (01) 106-116
    CrossrefPubMedSearch in Google Scholar